PPARG and obesity disorder: Additionally, OTCs, as TBT, are considered obesogenic chemicals, which cause hyperplasia and hypertrophy of adipocytes and thus promote mammalian obesity via peroxisome proliferator-activated receptor gamma (PPARγ) signaling [17, 18].